[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_fa4e84fd-d6c0-4b5d-a712-86ac477212af":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:fa4e84fd-d6c0-4b5d-a712-86ac477212af,\"}":77},{"code":4,"data":5,"meta":23},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":25,"manageAffiliations":26,"indexDatabases":27,"url":28,"thumbnailPath":23,"statistic":29,"gsStatistic":66,"type":76,"analyzePriority":23},"fa4e84fd-d6c0-4b5d-a712-86ac477212af","2023-05-10T11:31:36.982+00:00","2026-08-25T00:38:00.672+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Ph%E1%BA%ABu%20thu%E1%BA%ADt%20Tim%20m%E1%BA%A1ch%20v%C3%A0%20L%E1%BB%93ng%20ng%E1%BB%B1c%20Vi%E1%BB%87t%20Nam",{"country":12,"issn":14,"title":16,"gsId":19},{"VOID":13},"VN",{"VOID":15},"08667551",{"EN":17,"VI":18},"The Vietnam Journal of Cardiovascular and Thoracic Surgery","Tạp chí Phẫu thuật Tim mạch và Lồng ngực Việt Nam",{"VOID":20},"4OmG5aMAAAAJ","PUBLISHER","VERIFIED",null,18,[],[],[],"https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts",{"impactFactor":30,"impactFactorByYear":31,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":37,"totalCitation":49,"totalCitationByYear":50,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":57,"hindexLast5Year":51,"hindex":51},0,{"2021":32,"2022":33,"2023":34,"2024":35},0.05,0.04,0.07,0.03,549,{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},20,9,8,15,29,210,89,40,75,43,11,106,{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},4,1,60,3,7,0.19,{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},0.2,0.11,0.12,0.31,0.29,0.22,0.08,0.09,{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":68,"totalCitation":38,"totalCitationByYear":71,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":74,"hindexLast5Year":69,"hindex":69},23,{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},2,17,{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},5,0.87,{"2020":62,"2021":52,"2022":75},0.5,"JOURNAL",{"meta":78,"data":80},{"total":79},"607",[81,185,238,289,338,389,439,485,533,580],{"id":82,"createTime":83,"updateTime":84,"relativeEntities":85,"slug":86,"properties":87,"entityType":102,"verifyStatus":22,"verifyTime":103,"verifyNote":104,"languages":23,"translateLanguages":23,"viewCount":51,"primaryUrl":105,"fullTextUrl":106,"authors":107,"publicationType":151,"publisherRelationship":152,"citationCount":30,"citationInfo":177,"publishDate":180,"publishYear":178,"citationAnalyzeStatus":181,"lastCitationAnalyze":182,"indexDatabases":183,"openAccess":23,"references":23,"isForceReanalyzing":184},"4e6499c4-d019-481f-95ab-2867dafbd1a8","2023-09-26T07:03:53.947+00:00","2026-08-25T01:29:07.629+00:00",[],"%C4%90%C3%A1nh-gi%C3%A1-k%E1%BA%BFt-qu%E1%BA%A3-c%E1%BB%A7a-d%E1%BA%ABn-l%C6%B0u-d%E1%BB%8Bch-m%C3%A0ng-tim-b%E1%BA%B1ng-ch%E1%BB%8Dc-h%C3%BAt-kim-nh%E1%BB%8F-d%C6%B0%E1%BB%9Bi-h%C6%B0%E1%BB%9Bng-d%E1%BA%ABn-si%C3%AAu-%C3%A2m-%E1%BB%9F-b%E1%BB%87nh-nh%C3%A2n-tr%C3%A0n-d%E1%BB%8Bch-m%C3%A0ng-tim-sau-ph%E1%BA%ABu-thu%E1%BA%ADt-tim-t%E1%BA%A1i-B%E1%BB%87nh-vi%E1%BB%87n-Tim-H%C3%A0-N%E1%BB%99i",{"abstract":88,"title":91,"gsPaper":94,"keywords":96,"references":98,"doi":100},{"EN":89,"VI":90},"Background: Pericardial effusion is a relatively common complication after cardiac surgery, in which a large proportion of cardiac tamponade causes hemodynamic disturbances, and can have serious consequences.\r\nObjective: \"Evaluation of the efficacy and safety of pericardial drainage with ultrasound-guided fine-needle aspiration\". \r\nMethod: Cross-sectional, retrospective. Accept all patients with pericardial effusion after cardiac surgery were recruited at the Emergency Department and the Intensive Care Unit who performed pericardial aspiration from May 2021 to October 2022.\r\nResults: There were 46 patients included in the study; the average age is 52.04 ± 12.46 years, the youngest is 26 years, the oldest is 81 years old; The group of patients with heart valve disease had the highest rate of pericardial effusion, accounting for 93.4%; patients with atrial septal defect have recurrent pericardial effusion after surgery; there is a higher rate of recurrence and need for surgical conversion with the use of a sheet + pigtail device compared with a catheter; 36 (78.3%) patients did not have recurrent effusion and 10 (21.7%) patients had relapse; 100% of patients are alive after pericardial drainage.\r\nConclusion: The results of treatment of pericardial effusion with fine needle aspiration pericardial drainage under the guidance of ultrasound after cardiac surgery are positive, the use of the catheter is initially shown to be safer than the use of sheat + pigtail.","Đặt vấn đề: Tràn dịch màng ngoài tim là biến chứng gặp tương đối phổ biến sau phẫu thuật tim trong đó có một tỉ lệ không nhỏ chèn ép tim gây rối loạn huyết động, và có thể để lại hậu quả nghiêm trọng.\r\nMục tiêu: “Đánh giá hiệu quả và an toàn của dẫn lưu dịch màng tim bằng chọc hút kim nhỏ dưới hướng dẫn siêu âm”. \r\nPhương pháp nghiên cứu: phân tích cắt ngang, hồi cứu. Thu nhận tất cả người bệnh tràn dịch màng tim sau phẫu thuật tim tại Khoa cấp cứu và Khoa hồi sức tích cực được tiến hành chọc hút dịch màng tim từ tháng 5.2021 đến tháng 10.2022.\r\nKết quả: Có 46 người bệnh dược thu nhận vào nghiên cứu; tuổi trung bình là 52.04 ± 12.46 tuổi nhỏ nhất là 26, tuổi lớn nhất là 81; nhóm người bệnh với bệnh lý van tim có tỉ lệ tràn dịch màng tim cao nhất, chiếm 93.4%; người bệnh có thông liên nhĩ có tràn dịch màng tim sau phẫu thuật đều tái phát; có một tỉ lệ tái phát và cần chuyển phẫu thuật cao hơn khi dùng dụng cụ sheat + pigtail so với catheter; có 36 (78.3%) người bệnh không có tràn dịch tái phát và 10(21.7%) người bệnh có tái phát; 100% người bệnh đều sống sau dẫn lưu dịch màng ngoài tim.\r\nKết luận: Kết quả điều trị tràn dịch màng ngoài tim bằng chọc hút dẫn lưu dịch màng tim bằng kim nhỏ dưới hướng dẫn của siêu âm sau phẫu thuật tim là khả quan, sử dụng catheter bước đầu cho thấy an toàn hơn so với dùng sheat + pigtail",{"EN":92,"VI":93},"Evaluation of results of pericardial drainage by ultrasound-guided fine-needle aspiration in patients with pericardial effusion after cardiac surgery at hanoi heart hospital","Đánh giá kết quả của dẫn lưu dịch màng tim bằng chọc hút kim nhỏ dưới hướng dẫn siêu âm ở bệnh nhân tràn dịch màng tim sau phẫu thuật tim tại Bệnh viện Tim Hà Nội",{"VOID":95},"6129939535334334784",{"VI":97},"dẫn lưu dịch màng ngoài tim,chọc hút kim nhỏ,phẫu thuật dẫn lưu dịch màng tim,phẫu thuật tim,chèn ép tim",{"VOID":99},"Ikaheimo M. J., Huikuri H. V., Airaksinen K. E., et al. (1988), \"Pericardial effusion after cardiac surgery: incidence, relation to the type of surgery, antithrombotic therapy, and early coronary bypass graft patency\", Am Heart J, 116(1 Pt 1), pp. 97-102.\nBecit N., Unlu Y., Ceviz M., et al. (2005), \"Subxiphoid pericardiostomy in the management of pericardial effusions: case series analysis of 368 patients\", Heart, 91(6), pp. 785-90.\nAshikhmina E. A., Schaff H. V., Sinak L. J., et al. (2010), \"Pericardial effusion after cardiac surgery: risk factors, patient profiles, and contemporary management\", Ann Thorac Surg, 89(1), pp. 112-118.\nN.T.D.Hưng(2016), “Nghiên cứu một số yếu tố nguy cơ và điều trị tràn dịch màng ngoài tim sau phẫu thuật tim mở”. Luận văn bác sĩ nội trú. Học viện Quân Y.\nLê Quang Thứu (2012), \"Hội chứng Tràn dịch màng ngoài tim sau mở màng tim\", Tạp chí Y Dược học - Trường đại học Y Dược Huế, 12, tr. 66-71.\nEryilmaz S., Emiroglu O., Eyileten Z., et al. (2006), \"Effect of posterior pericardial drainage on the incidence of pericardial effusion after ascending aortic surgery\", J Thorac Cardiovasc Surg, 132(1), pp. 27-31.\nKing TE, Stelzner TJ, Sahn SA.(1983) “Cardiac tamponade complicating the postpericardiotomy syndrome”. Chest1983;84:500–503.\nOfori-Krakye S, Tybert TI, Geha AS, Hammond GL, Cohen LS, Langou RA.(1981) “Late cardiac tamponade after open heart surgery: incidence, role of anticoagulants in its pathogenesis and its relationship to the postpericardiotomy syndrome”. Circulation1981;63:1323–1328\nBeco G, Mambour N, V^o C, Vanhoutte L, Moniotte S, Poncelet A, et al.(2018), “Recent experience and follow-up after surgical closure of secundum atrial septal defect in 120 children”. Pediatr Cardiol. 2018;39:1440-4.\nHeching HJ, Bacha EA, Liberman L.(2015), “Post pericardiotomy syndrome in pediatric patients following surgical closure of secundum atrial septal defects: incidence and risk factors”.Pediatr Cardiol. 2015;36:498-50\nElias MD, Glatz AC, O’Connor MJ, Schachtner S, Ravishankar C, Mascio CE, et al.(2017) “Prevalence and risk factors for pericardial effusions requiring readmission after pediatric cardiac surgery”. Pediatr Cardiol. 2017;38:484-94\nJones DA, Radford DJ, Pohlner PG.(2001), “Outcome following surgical closure of secundum atrial septal defect”.J Paediatr Child Health. 2001;37:274-7",{"VOID":101},"10.47972\u002Fvjcts.v43i.1005","PUBLICATION","2023-09-26T07:03:53.945+00:00","190154","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F1005","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fdownload\u002F1005\u002F566",[108,128,144],{"id":109,"sortIndex":30,"researcher":23,"roles":110,"affiliations":111,"properties":125,"displayName":127,"givenName":23,"familyName":23},"60460e49-1c1b-44bb-b19a-360ff4602ebc",[],[112],{"id":113,"sortIndex":30,"affiliation":114,"properties":123},"d8dbc8bb-e44c-4edd-ad9c-c07d914154e6",{"id":113,"createTime":23,"updateTime":23,"relativeEntities":115,"slug":23,"properties":116,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":121,"parentIds":122,"statistic":23},[],{"title":117,"country":120},{"EN":118,"VI":119},"Hanoi Heart Hospital","Bệnh viện tim Hà Nội",{"VOID":13},"http:\u002F\u002Fbenhvientimhanoi.vn\u002F",[],{"title":124},{"VI":118},{"title":126},{"VI":127},"Nguyễn  Văn Thực",{"id":129,"sortIndex":30,"researcher":23,"roles":130,"affiliations":131,"properties":141,"displayName":143,"givenName":23,"familyName":23},"c8e5cd20-d161-408a-a712-290ba780636f",[],[132],{"id":113,"sortIndex":30,"affiliation":133,"properties":139},{"id":113,"createTime":23,"updateTime":23,"relativeEntities":134,"slug":23,"properties":135,"entityType":23,"verifyStatus":23,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":23,"url":121,"parentIds":138,"statistic":23},[],{"title":136,"country":137},{"EN":118,"VI":119},{"VOID":13},[],{"title":140},{"VI":118},{"title":142},{"VI":143},"Trần Thanh Hoa",{"id":145,"sortIndex":30,"researcher":23,"roles":146,"affiliations":147,"properties":148,"displayName":150,"givenName":23,"familyName":23},"7d8f24fa-5d39-4512-8bef-1f7e5d4d098a",[],[],{"title":149},{"VI":150},"Đinh  Hải Nam","ARTICLE",{"url":105,"publisher":153,"properties":172},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":154,"slug":10,"properties":155,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":160,"manageAffiliations":161,"indexDatabases":162,"url":28,"thumbnailPath":23,"statistic":163,"gsStatistic":168,"type":76,"analyzePriority":23},[],{"country":156,"issn":157,"title":158,"gsId":159},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":164,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":165,"totalCitation":49,"totalCitationByYear":166,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":167,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":169,"totalCitation":38,"totalCitationByYear":170,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":171,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"pages":173,"volume":175},{"VOID":174},"58 - 66",{"VOID":176},"43",{"total":30,"publishYear":178,"statisticByYear":179},2023,{},"2023-08-28","ERROR_IN_ANALYZE_CITATION","2026-08-25T01:29:07.628+00:00",[],false,{"id":186,"createTime":187,"updateTime":188,"relativeEntities":189,"slug":190,"properties":191,"entityType":102,"verifyStatus":22,"verifyTime":187,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":69,"primaryUrl":206,"fullTextUrl":23,"authors":207,"publicationType":151,"publisherRelationship":208,"citationCount":30,"citationInfo":232,"publishDate":235,"publishYear":233,"citationAnalyzeStatus":181,"lastCitationAnalyze":236,"indexDatabases":237,"openAccess":23,"references":23,"isForceReanalyzing":184},"df74bcc3-e1ae-4cff-9c25-2ce8de7e99af","2023-05-16T02:29:36.836+00:00","2026-08-25T01:28:34.507+00:00",[],"K%E1%BA%BFt%20qu%E1%BA%A3%20%C4%91i%E1%BB%81u%20tr%E1%BB%8B%20b%E1%BB%87nh%20%C4%91%E1%BB%99ng%20m%E1%BA%A1ch%20chi%20d%C6%B0%E1%BB%9Bi%20b%E1%BA%B1ng%20ph%E1%BA%ABu%20thu%E1%BA%ADt%20ph%E1%BB%91i%20h%E1%BB%A3p%20v%E1%BB%9Bi%20can%20thi%E1%BB%87p%20m%E1%BA%A1ch%20m%C3%A1u%20m%E1%BB%99t%20th%C3%AC%20%28Hybrid%29%20t%E1%BA%A1i%20b%E1%BB%87nh%20vi%E1%BB%87n%20h%E1%BB%AFu%20ngh%E1%BB%8B%20Vi%E1%BB%87t%20%C4%90%E1%BB%A9c%20giai%20%C4%91o%E1%BA%A1n%202014%20-%202015",{"abstract":192,"title":195,"gsPaper":197,"keywords":199,"references":201,"doi":203},{"EN":193,"VI":194},"Combining open surgery and endovascular interventions (Hybrid) for peripheral artery disease (PAD) were first conducted in Viet-Duc hospital since 2011 with good initial results. We continue this therapy for patients with PAD in 2014 - 2015 Results: 14 patients were treated including 8 stage III patients, 6 stage IV patients (Leriche-Fontaine's classification). Only one female patient, Average age of patients was 72.7. There are 28.6% patients had previous CVA lesions, 21.4% patients with carotid or coronary lesions. All patients were reduced \u002Ffree from pain after treatment. Ankle Brachial Index (ABI) rose from 0.32 to 0.73. Only one patient required major amputation. Minor amputation after treatment accounted for 21.43%. No technical complications happen during treatment. Hybrid for multi-stage lesions of PAD remains safety, effective and feasible.","Phối hợp phẫu thuật và can thiệp nội mạch một thí (hybrid) cho bệnh mạch máu chi dưới đã được tiến hành tại bệnh viện Việt Đức t 2011 với kết quả ban đầu tương đối tốt. Chúng tôi tiếp tục tiến hành biện pháp điều trị này cho BN có chỉ định giai đoạn 2014-2015. Kết quả: có 14 BN được tiến hành điều trị trong đó có 8 BN thiếu máu giai đoạn III, 6 BN thiếu máu giai đoạn IV theo phân loại Leriche-Fontaine. Chỉ có 1 BN nữ, tuổi trung bính của BN là 72,7. Có 28,6 BN có tổn thương TBMN cũ, 21,4 BN có tổn thương mạch cảnh hoặc mạch vành cần can thiệp kèm theo. Tất cả các BN đều giảm\u002F hết đau sau điều trị. ABI trung bính của chi đau tăng t 0,32 lên 0,73. Chỉ có một BN phải cắt cụt 1\u002F3 dưới cẳng chân do có hoại tử bàn chân t trước. Tắc cầu nối sau mổ gặp 1 trường hợp. Cắt cụt tối thiếu sau điều trị chỉ chiếm 21,43 . Không có biến chứng về kỹ thuật trong quá trính điều trị. Hybrid cho những tổn thương nhiều tầng của bệnh ĐM chi dưới vẫn là một biện pháp an toàn, hiệu quả và nên được áp dụng. Từ k óa: Bệnh ĐM chi dưới, Phẫu thuật mạch máu, can thiệp mạch máu, hybrid",{"VI":196},"Kết quả điều trị bệnh động mạch chi dưới bằng phẫu thuật phối hợp với can thiệp mạch máu một thì (Hybrid) tại bệnh viện hữu nghị Việt Đức giai đoạn 2014 - 2015",{"VOID":198},"5430176704387590795",{"VI":200},"Bệnh ĐM chi dƣới, Phẫu thuật mạch máu, can thiệp mạch máu, hybrid",{"VOID":202},"Đoàn Quốc Hưng. (2011) Can thiệp nội mạch và phối hợp phẫu thuật mổ mở-can thiệp nội mạch: xu hướng mới trong điều trị bệnh mạch máu . Tạp chì nghiên cứu y học: 80;354: 64-60.\nNguyễn Duy Thắng, Đoàn Quốc Hưng, Nguyễn Hữu Ước, Phạm Quốc Đạt (2013) Kết quả phối hợp phẫu thuật và can thiệp nội mạch một thí (Hybrid) trong điều trị bệnh lý mạch máu tại bệnh viện hữu nghị Việt Đức . Tạp chì y học thực hành số 7(876): 43-46\nĐoàn Quốc Hưng, Nguyễn Duy Thắng, Nguyễn Hữu Ước, Lê Thanh Dũng, Nguyễn Lân Hiếu (2014) Điều trị bệnh mạch máu phức tạp bằng can thiệp nội mạch phối hợp phẫu thuật (Hybrid) Tạp chì tim mạch học Việt Nam số 65: 34-41.\nAlan T. Hirsch et al. (2006) ACC\u002FAHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic) . Circulation.113:e463-e654\nMichal Tendera et al (The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)) (2011) ESC Guidelines on the diagnosis and treatment of peripheral artery diseases European Heart Journal 32, 2851–2906.\nRooke Twet al. (2011) ACCF\u002FAHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline) . Catheter Cardiovasc Interv. 2012 Mar 1;79(4):501-31.\nPorter JM, Eidemiller LR, Dotter CT, Rösch J, Vetto RM: (1973) Combined arterial dilatation and femorofemoral bypass for limb salvage . Surg Gynecol Obstet 137:409–412.\nGoodney P.Philip, R. M. Zwolak. (2009) National trends in lower extremity bypass surgery, endovascular intervention, and major amputations. J Vasc Surg 50:54-60\nOrtiz D1, Jahangir A1, Singh M1, Allaqaband S1, Bajwa TK1, Mewissen MW2 2014 Access site complications after peripheral vascular interventions: incidence, predictors, and outcomes . Circ Cardiovasc Interv. Dec;7(6):821-8.\nKenneth Ouriel (2001) Peripheral arterial disease Lancet; 358: 1257–64.",{"VOID":204},"10.47972\u002Fvjcts.v15i.156","480d1676-b957-46bc-b7e7-5316333f1b47","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F156",[],{"url":206,"publisher":209,"properties":228},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":210,"slug":10,"properties":211,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":216,"manageAffiliations":217,"indexDatabases":218,"url":28,"thumbnailPath":23,"statistic":219,"gsStatistic":224,"type":76,"analyzePriority":23},[],{"country":212,"issn":213,"title":214,"gsId":215},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":220,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":221,"totalCitation":49,"totalCitationByYear":222,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":223,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":225,"totalCitation":38,"totalCitationByYear":226,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":227,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":229},{"EN":230,"VI":231},"Vol. 11","Tập 11",{"total":30,"publishYear":233,"statisticByYear":234},2020,{},"2020-11-02","2026-08-25T01:28:34.506+00:00",[],{"id":239,"createTime":240,"updateTime":241,"relativeEntities":242,"slug":243,"properties":244,"entityType":102,"verifyStatus":22,"verifyTime":240,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":30,"primaryUrl":259,"fullTextUrl":23,"authors":260,"publicationType":151,"publisherRelationship":261,"citationCount":30,"citationInfo":283,"publishDate":286,"publishYear":284,"citationAnalyzeStatus":181,"lastCitationAnalyze":287,"indexDatabases":288,"openAccess":23,"references":23,"isForceReanalyzing":184},"ba3c297d-9c0d-45cd-bdac-a95ff3656612","2023-05-16T02:32:13.221+00:00","2026-08-25T01:27:29.495+00:00",[],"Study%20in%20variations%20of%20serum%20troponin-tlevels%20in%20patients%20after%20heart%20valve%20surgery",{"abstract":245,"title":248,"gsPaper":251,"keywords":253,"references":255,"doi":257},{"EN":246,"VI":247},"Background:    The    concentration    of    serum 1.051±0.898ng\u002Fml .There was no correlation between serum troponin T levels and factors of with age, sex, PAP. We found the correlationbetween TnTlevels and factors of cardiac functions (EF, NYHA, LVtdD),complex features of interventions (number of valves intervented, aortic clamping time, cardiopulmonarybypass time), results of intensive care (incidences of acute renal failure, of renal replacement therapy, of   low cardiac output, of inotrope using; andartificialventilation time andICU time). Conclusion: Troponin-T levelin postoperative period isamarkerofmyocardial damage of patients undergoing heart valve surgery. It should be considered as an early prognostic factor after heart valve surgery.\r\n ","Trong phẫu thuật tim, nồng độ Troponin-T huyết thanh gia tăng ở tất cả các bệnh nhân sau mổ, đỉnh cao nhất ở thời điểm 4 giờ sau mở cặp động mạch chủ là 1,184 ± 0,675ng\u002Fml. Sau đó, biến thiên nồng độ Troponin-T giảm dần và giá trị này ở thời điểm 24 giờ sau mở cặp động mạch chủlà 1,051±0,898ng\u002Fml. Không có mối liên quan giữa nồng độ Troponin-T huyết thanh sau phẫu thuật vớicác yếu tổ về tuổi, giới, tăng áp lực động mạch phổitrước phẫu thuật. Có mối liên  quan  giữa  nồng  độ  TnT  sau  mổ  với  các  yếu tốđánh giá chức năng tim (NYHA, EF, LVtdD), và với các yếu tố nguy cơ (thời gian cặp động mạch chủ, thời gian tuần hoàn ngoài cơ thể, số van tim được can thiệp, thời gian thở máy, thời gian nằm hồi sức, suy thận cấp và trạng cung lượng tim thấp). Kết luận: Nồng độ Troponin-T sau phẫu thuật là một chỉ điểm mức độ tổn thương cơ tim trong quá trình phẫu thuật có giá trị tiên lượng sớm ở các bệnh nhânsau phẫu thuật van tim.",{"EN":249,"VI":250},"Study in variations of serum troponin-tlevels in patients after heart valve surgery","NGHIÊN CỨU SỰ BIẾN ĐỔI NỒNG ĐỘ TROPONIN-T HUYẾT THANH Ở BỆNH NHÂN SAU PHẪU THUẬT VAN TIM",{"VOID":252},"14317849379007282464",{"VI":254},"Troponin T, phẫu thuật van tim, yếu tố tiên lượng trong phẫu thuật tim",{"VOID":256},"Bonow R. O. , Carabello B., Edmunds L. Henry (2006), \"Guidelines for the management of patients with valvular heart disease\", ACC\u002FAHA practice guidelines, pp.1949 – 1984.\nLehrke Stephanie and al (2000), \"Cardiac Troponin T for Prediction of Short- and Long- Term Morbidity and Mortality after Elective Open Heart Surgery\", Clinical Chemistry 50, pp. 1560- 1567.\nLurati Buse Giovana A. and al (2009), “12- Month Outcome after cardiac surgery: Prediction by Troponin T in Combination With the European system for Cardiac Operative Risk Evaluation”, The Society of Thoracic Surgeons, pp.1806- 1811.\nNesher Nahum and al (2008), \"TnT after Cardiac Surgery: A Predictor or a Phenomenon\", The Society of Thoracic Surgeons, pp. 1348- 1354.\nVermes Emmanuelle and al (2000), “Cardiac Troponin I release after open Heart Surgery: A Marker of Myocardial Protection”, The Society of Thoracic Surgeons, pp. 087-2090.",{"VOID":258},"10.47972\u002Fvjcts.v3i.304","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F304",[],{"url":259,"publisher":262,"properties":281},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":263,"slug":10,"properties":264,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":269,"manageAffiliations":270,"indexDatabases":271,"url":28,"thumbnailPath":23,"statistic":272,"gsStatistic":277,"type":76,"analyzePriority":23},[],{"country":265,"issn":266,"title":267,"gsId":268},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":273,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":274,"totalCitation":49,"totalCitationByYear":275,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":276,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":278,"totalCitation":38,"totalCitationByYear":279,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":280,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":282},{"EN":230,"VI":231},{"total":30,"publishYear":284,"statisticByYear":285},2013,{},"2013-06-13","2026-08-25T01:27:29.494+00:00",[],{"id":290,"createTime":291,"updateTime":292,"relativeEntities":293,"slug":294,"properties":295,"entityType":102,"verifyStatus":22,"verifyTime":291,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":51,"primaryUrl":309,"fullTextUrl":23,"authors":310,"publicationType":151,"publisherRelationship":311,"citationCount":30,"citationInfo":333,"publishDate":336,"publishYear":334,"citationAnalyzeStatus":181,"lastCitationAnalyze":292,"indexDatabases":337,"openAccess":23,"references":23,"isForceReanalyzing":184},"147a726f-8ef0-4b7e-9661-0da4c1a08090","2023-05-16T02:24:31.111+00:00","2026-08-25T01:27:10.944+00:00",[],"M%E1%BB%91i%20li%C3%AAn%20quan%20gi%E1%BB%AFa%20gi%E1%BA%A3m%20bi%E1%BA%BFn%20thi%C3%AAn%20nh%E1%BB%8Bp%20tim%20v%E1%BB%9Bi%20bi%E1%BA%BFn%20c%E1%BB%91%20tim%20m%E1%BA%A1ch%20ch%C3%ADnh%20sau%20ph%E1%BA%ABu%20thu%E1%BA%ADt%20c%E1%BA%A7u%20n%E1%BB%91i%20ch%E1%BB%A7%20v%C3%A0nh",{"abstract":296,"title":299,"gsPaper":301,"keywords":303,"references":305,"doi":307},{"EN":297,"VI":298},"Introduction and objectives: Previous studies have shown that after coronary artery bypass grafting (CABG), heart rate variability (HRV) becomes decreased. The aim of this study was to evaluate the role of decreased heart rate variability in coronary artery bypass grafting patients. Methods: The study involved 119 consecutive patients who underwent the first CABG operation with sinus rhythm. All subjects underwent assessed with 24-hour Holter recordings 2 days preoperative and 7 days postoperative at Hanoi Heart Hospital from 6\u002F2016 to 8\u002F2018. Major adverse cardiovascular events was defined as cardiac death, recurrent myocardial infarction, stroke, decompensated heart failure and re-hospitalization. The patients were followed up for 6 months. Main results: The incidence of major adverse cardiovascular events was 10.8% followed to 6 months. The incidence of pre and postoperative low HRV varies from 28.6% (preop) to 51.8% (postop 7 days). In which, decreased HRV preoperative predictors of major adverse cardiac events in patients undergoing coronary artery bypass graft surgery: followed up for 3 months: (OR:3,40; 95%CI: 0,97 – 12,11; p>0,05), followed up for 6 months (OR:3,41; 95%CI: 1,05 – 11,05; p<0,05). Conclusions: Preoperative with low HRV was pedict a risk factor for major adverse cardiovascular events.","TÓM TẮT: Thay đổi biến thiên nhịp tim (BTNT) được biết đến ở bệnh nhân phẫu thuật cầu nối chủ vành (CNCV). Mục tiêu của nghiên cứu này là đánh giá ảnh hưởng của giảm BTNT đối với các biến cố tim mạch chính sau phẫu thuật CNCV. Đối tượng và phương pháp nghiên cứu: tiến cứu mô tả theo dõi dọc 119 bệnh nhân phẫu thuật CNCV tại Bệnh viện Tim Hà Nội từ 6\u002F2016 đến 8\u002F2018. Đánh giá BTNT bằng Holter điện tâm đồ (ĐTĐ) 24 giờ tại thời điểm 2 ngày trước và sau phẫu thuật 7 ngày. Theo dõi các biến cố tim mạch đến 6 tháng sau phẫu thuật CNCV. Kết quả: Tỉ lệ giảm BTNT trước phẫu thuật là 28,6%, sau phẫu thuật 7 ngày là 51,8%. Biến cố tim mạch chính sau 3 tháng và sau 6 tháng là 9,2% và 10,8%. Trong đó, giảm BTNT trước phẫu thuật có xu hướng làm tăng tần số biến cố tim mạch chính lên 3,40 lần khi theo dõi đến 3 tháng sau phẫu thuật (OR: 3,40; 95%CI: 0,97 – 12,11; p>0,05). Giảm BTNT trước phẫu thuật làm tăng nguy cơ xuất hiện biến cố tim mạch chính lên 3,41 lần khi theo dõi đến 6 tháng sau phẫu thuật (OR: 3,41; 95%CI: 1,05 – 11,05; p<0,05). Chưa thấy mối liên quan giữa giảm BTNT tại thời điểm 7 ngày sau phẫu thuật với các biến cố tim mạch chính theo dõi đến 3 (OR: 1,96; 95%CI: 0,46 – 8,27; p>0,05) và 6 tháng (OR: 2,33; 95%CI: 0,57 – 9,54; p>0,05). Kết luận: Giảm BTNT trước phẫu thuật có mối liên quan tới biến cố tim mạch, trong khi đó giảm BTNT sau phẫu thuật chưa thấy mối liên quan này.",{"EN":300,"VI":300},"Mối liên quan giữa giảm biến thiên nhịp tim với biến cố tim mạch chính sau phẫu thuật cầu nối chủ vành",{"VOID":302},"2157084784584078070",{"VI":304},"biến thiên nhịp tim,phẫu thuật cầu nối chủ vành",{"VOID":306},"Mosorin M., Lantos M., Juvonen T. et al (2015), \"Five-Year Outcome after Coronary Artery Bypass Surgery in Survivors of Out-of-Hospital Cardiac Arrest\", Front Surg, 2: pp. 2.\nMccraty R. and Shaffer F. (2015), \"Heart Rate Variability: New Perspectives on Physiological Mechanisms, Assessment of Self-regulatory Capacity, and Health risk\", Glob Adv Health Med, 4(1): pp. 46-61.\nTatiana Mironova, Vladimir Mironov and Kuvatov. Elena Kuvatova and Vladimir (2017), \"Heart Rate Variability Analysis Before and During Coronary Artery Bypass Graft Surgery\", Clin Surg, 2(1559).\nMilicevic G., Fort L., Majsec M. et al (2004), \"Heart rate variability decreased by coronary artery surgery has no prognostic value\", Eur J Cardiovasc Prev Rehabil, 11(3): pp. 228-32.\nDemirel S., Akkaya V., Oflaz H. et al (2002), \"Heart rate variability after coronary artery bypass graft surgery: a prospective 3-year follow-up study\", Ann Noninvasive Electrocardiol, 7(3): pp. 247-50.\nSimov D., Matveev M., Milanova M. et al (2014), \"Cardiac Autonomic Innervation Following Coronary Artery Bypass Grafting Evaluated by High Resolution Heart Rate Variability \", Computing in Cardiology, 41: pp. 1013-16.\nMaycon Jr. Ferreira and Zanesco. Angelina (2016), \"Heart rate variability as important approach for assessment autonomic modulation\", Motriz - Rio Claro, 22(2): pp. 3-8.",{"VOID":308},"10.47972\u002Fvjcts.v35i.688","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F688",[],{"url":309,"publisher":312,"properties":331},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":313,"slug":10,"properties":314,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":319,"manageAffiliations":320,"indexDatabases":321,"url":28,"thumbnailPath":23,"statistic":322,"gsStatistic":327,"type":76,"analyzePriority":23},[],{"country":315,"issn":316,"title":317,"gsId":318},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":323,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":324,"totalCitation":49,"totalCitationByYear":325,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":326,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":328,"totalCitation":38,"totalCitationByYear":329,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":330,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":332},{"EN":230,"VI":231},{"total":30,"publishYear":334,"statisticByYear":335},2021,{},"2021-12-29",[],{"id":339,"createTime":340,"updateTime":341,"relativeEntities":342,"slug":343,"properties":344,"entityType":102,"verifyStatus":22,"verifyTime":358,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":30,"primaryUrl":359,"fullTextUrl":23,"authors":360,"publicationType":151,"publisherRelationship":361,"citationCount":30,"citationInfo":383,"publishDate":386,"publishYear":384,"citationAnalyzeStatus":181,"lastCitationAnalyze":387,"indexDatabases":388,"openAccess":23,"references":23,"isForceReanalyzing":184},"854f5d3b-4c09-4ad3-855a-d6c75abd73b7","2023-05-16T02:24:56.634+00:00","2026-08-25T01:25:26.561+00:00",[],"K%E1%BA%BFt%20qu%E1%BA%A3%20ph%E1%BA%ABu%20thu%E1%BA%ADt%20s%E1%BB%ADa%20to%C3%A0n%20b%E1%BB%99%20k%E1%BB%87nh%20nh%C4%A9%20th%E1%BA%A5t%20to%C3%A0n%20ph%E1%BA%A7n%20t%E1%BA%A1i%20B%E1%BB%87nh%20vi%E1%BB%87n%20Tim%20H%C3%A0%20N%E1%BB%99i",{"abstract":345,"title":348,"gsPaper":350,"keywords":352,"references":354,"doi":356},{"EN":346,"VI":347},"Background: complete atrioventricular canal defect is a complex congenital heart disease. The current trend is to perform early complete repair to avoid the progression of pulmonary vascular disease and congestive heart failure. We sought to describe characteristics and evaluate outcomes of definitive repair of complete atrioventricular canal defect at Hanoi Heart Hospital from 2017  to 2020.[1]\r\nMethods: a retrospective descriptive study of 62 patients who underwent definitive repair of complete atrioventricular canal defect at Hanoi Heart Hospital from January 2017 to December 2020. Data processing using SPSS 22 software.\r\nResults: mean age at the time of surgery was 17.56 ± 30.85 months, 59.7% had Down phenotype. The type of surgical repair was single-patch technique (32.2%), modified single-patch technique (6.5%), and two-patch technique (61.3%) The most common postoperative complication is pneumonia (40.32%) and other complications include: pericardial effusion or pleural effusion (14.52%), third-degree AV block (9.67%), acute renal failure (6.45%). 3 cases (4.8%) required early reoperations, operative mortality was 1.6%. The overall estimated survival was 96,8% at 1 and 5 years.\r\nConclusion: definitive repair of complete atrioventricular canal defect at Hanoi Heart Hospital has good early and medium-term results.","Đặt vấn đề: kênh nhĩ thất toàn phần là một bệnh lý tim bẩm sinh phức tạp. Xu hướng hiện nay là tiến hành phẫu thuật sửa chữa triệt để trong thời gian sớm để tránh những triến triển bệnh lý mạch phổi và suy tim xung huyết. Nghiên cứu này nhằm: nhận xét đặc điểm và đánh giá kết quả phẫu thuật sửa toàn bộ kênh nhĩ thất toàn phần tại Bệnh viện Tim Hà Nội giai đoạn 2017 – 2020.\r\nĐối tượng phương pháp nghiên cứu: nghiên cứu mô tả hồi cứu 62 BN được phẫu thuật sửa toàn bộ kênh nhĩ thất toàn phần tại Bệnh viện Tim Hà Nội từ tháng 1\u002F2017 đến tháng 12\u002F2020. Xử lý số liệu bằng phần mềm SPSS22.\r\nKết quả: tuổi trung bình tại thời điểm phẫu thuật là 17,56 ± 30,85 tháng, 59,7% có kiểu hình Down. 32,2% dùng kỹ thuật một miếng vá, 6,5% dùng kỹ thuật một miếng vá cải tiến, và 61,3% dùng kỹ thuật hai miếng vá. Biến chứng hay gặp nhất sau mổ là viêm phổi (40,32 %) các biến chứng khác bao gồm: tràn dịch màng tim, màng phổi (14,52 %), Block nhĩ thất độ III (9,67 %), suy thận cấp (6,45 %). 3 trường hợp (4,8%) phải mổ lại sớm, 1 trường hợp tử vong phẫu thuật (1,6%). Tỷ lệ sống sau mổ 1 năm và 5 năm là 96,8%.\r\nKết luận: kết quả sửa toàn bộ bệnh lý kênh nhĩ thất toàn phần tại Bệnh viện Tim Hà Nội cho thấy kết quả sớm và trung hạn tốt.",{"EN":349,"VI":349},"Kết quả phẫu thuật sửa toàn bộ kệnh nhĩ thất toàn phần tại Bệnh viện Tim Hà Nội",{"VOID":351},"14519473379864613995",{"VI":353},"kênh nhĩ thất toàn phần",{"VOID":355},"Long-term outcomes after surgical repair of complete atrioventricular septal defect | Elsevier Enhanced Reader. doi:10.1016\u002Fj.jtcvs.2015.05.011\nAtz AM, Hawkins JA, Lu M, et al. Surgical management of complete atrioventricular septal defect: Associations with surgical technique, age, and trisomy 21. J Thorac Cardiovasc Surg. 2011;141(6):1371-1379. doi:10.1016\u002Fj.jtcvs.2010.08.093\nBuratto E, Hu T, Lui A, et al. Early repair of complete atrioventricular septal defect has better survival than staged repair after pulmonary artery banding: A propensity score–matched study. J Thorac Cardiovasc Surg. 2021;161(5):1594-1601. doi:10.1016\u002Fj.jtcvs.2020.07.106\nXie O, Brizard CP, d’Udekem Y, et al. Outcomes of repair of complete atrioventricular septal defect in the current era. Eur J Cardiothorac Surg. 2014;45(4):610-617. doi:10.1093\u002Fejcts\u002Fezt444\nSchleiger A, Miera O, Peters B, et al. Long-term results after surgical repair of atrioventricular septal defect. Interact Cardiovasc Thorac Surg. 2019;28(5):789-796. doi:10.1093\u002Ficvts\u002Fivy334\nSt. Louis JD, Jodhka U, Jacobs JP, et al. Contemporary outcomes of complete atrioventricular septal defect repair: Analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database. J Thorac Cardiovasc Surg. 2014;148(6):2526-2531. doi:10.1016\u002Fj.jtcvs.2014.05.095\nRepair of complete atrioventricular septal defects in patients weighing less than 5 kg - ScienceDirect. Accessed May 1, 2022. https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fabs\u002Fpii\u002FS0003497503021714\nGoutallier CS, Buratto E, Schulz A, et al. Repair of complete atrioventricular septal defect between 2 and 3.5 kilograms: Defining the limits of safe repair. J Thorac Cardiovasc Surg. Published online February 25, 2022. doi:10.1016\u002Fj.jtcvs.2022.02.031\nAiraksinen R, Mattila I, Jokinen E, et al. Complete Atrioventricular Septal Defect: Evolution of Results in a Single Center During 50 Years. Ann Thorac Surg. 2019;107(6):1824-1830. doi:10.1016\u002Fj.athoracsur.2019.01.020.\nWilcox BR, Jones DR, Frantz EG, et al. Anatomically sound, simplified approach to repair of “complete” atrioventricular septal defect. Ann Thorac Surg. 1997;64(2):487-493; discussion 493-494. doi:10.1016\u002FS0003-4975(97)00566-3.",{"VOID":357},"10.47972\u002Fvjcts.v39i.801","2023-05-16T02:24:56.633+00:00","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F801",[],{"url":359,"publisher":362,"properties":381},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":363,"slug":10,"properties":364,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":369,"manageAffiliations":370,"indexDatabases":371,"url":28,"thumbnailPath":23,"statistic":372,"gsStatistic":377,"type":76,"analyzePriority":23},[],{"country":365,"issn":366,"title":367,"gsId":368},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":373,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":374,"totalCitation":49,"totalCitationByYear":375,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":376,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":378,"totalCitation":38,"totalCitationByYear":379,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":380,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":382},{"EN":230,"VI":231},{"total":30,"publishYear":384,"statisticByYear":385},2022,{},"2022-10-31","2026-08-25T01:25:26.560+00:00",[],{"id":390,"createTime":391,"updateTime":392,"relativeEntities":393,"slug":394,"properties":395,"entityType":102,"verifyStatus":22,"verifyTime":391,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":69,"primaryUrl":409,"fullTextUrl":23,"authors":410,"publicationType":151,"publisherRelationship":411,"citationCount":30,"citationInfo":433,"publishDate":436,"publishYear":434,"citationAnalyzeStatus":181,"lastCitationAnalyze":437,"indexDatabases":438,"openAccess":23,"references":23,"isForceReanalyzing":184},"89701e06-c4bd-4703-88bd-a2984ef8c56a","2023-05-16T02:21:43.708+00:00","2026-08-25T01:25:13.972+00:00",[],"Ph%E1%BA%ABu%20thu%E1%BA%ADt%20n%E1%BB%99i%20soi%20to%C3%A0n%20b%E1%BB%99%20t%E1%BA%A1o%20h%C3%ACnh%20th%C3%A0nh%20b%C3%AAn%20nh%C4%A9%20tr%C3%A1i%20%E1%BB%9F%20b%E1%BB%87nh%20nh%C3%A2n%20u%20nh%E1%BA%A7y%20nh%C4%A9%20tr%C3%A1i%20ph%E1%BB%A9c%20t%E1%BA%A1p",{"abstract":396,"title":398,"gsPaper":401,"keywords":403,"references":405,"doi":407},{"VI":397},"Phẫu thuật nội soi toàn bộ đã được ứng dụng tại một số trung tâm trên thế giới để điều trị u nhầy nhĩ, tuy nhiên chỉ định vẫn còn hạn chế, nhất là trong những trường hợp u phức tạp.\r\nCa lâm sàng: Bệnh nhân nữ, 59 tuổi có khối u nhầy nhĩ trái lớn, cuống rộng bám vào vách liên nhĩ, thành sau và thành bên nhĩ trái,đã được phẫu thuậtnội soi toàn bộ cắt u triệt để và tạo hình lại thành nhĩ trái.\r\nKết luận: Những trường hợp u nhầy nhĩ có giải phẫu phức tạp vẫn có thể được điều trị triệt để, an toàn bằng phẫu thuật nội soi toàn bộ với ê-kíp phẫu thuật có kinh nghiệm.",{"EN":399,"VI":400},"Phẫu thuật nội soi toàn bộ tạo hình thành bên nhĩ trái ở bệnh nhân u nhầy nhĩ trái phức tạp","PHẪU THUẬT NỘI SOI TOÀN BỘ TẠO HÌNH THÀNH BÊN NHĨ TRÁI Ở BỆNH NHÂN U NHẦY NHĨ TRÁI PHỨC TẠP",{"VOID":402},"5161221360826664675",{"VI":404},"u nhầy nhĩ trái, phẫu thuật nội soi toàn bộ, tạo hình nhĩ trái",{"VOID":406},"Castillo, J.G. and G. Silvay, Characterization and management of cardiac tumors. Semin Cardiothorac Vasc Anesth, 2010. 14(1): p. 6-20.\nGao, C., et al., Totally robotic resection of myxoma and atrial septal defect repair. Interact Cardiovasc Thorac Surg, 2008. 7: p. 947-50.\nGao, C., et al., Excision of atrial myxoma using robotic technology. The Journal of Thoracic and Cardiovascular Surgery. 139(5): p. 1282-1285.\nOnan, B., et al., Robotic resection of giant left ventricular myxoma causing outflow tract obstruction. J Card Surg, 2017. 32(5): p. 281-284.\nCottini, M., et al., Posterior wall as atypical localization of left atrial myxoma: Diagnosis and management. Herz, 2017. 42(4): p. 390-394.\nGao, C., et al., Excision of atrial myxoma using robotic technology. J Thorac Cardiovasc Surg, 2010. 139(5): p. 1282-5.\nSchilling, J., et al., Robotic excision of atrial myxoma. J Card Surg, 2012. 27(4): p. 423-6.\nDang, Q.H., et al., Totally Endoscopic Resection of Giant Left Atrial Myxoma Without Robotic Assistance. Innovations (Phila), 2018. 13(2): p. 136-139.\nYang, M., et al., Comparison of postoperative quality of life for patients who undergo atrial myxoma excision with robotically assisted versus conventional surgery. J Thorac Cardiovasc Surg, 2015. 150(1): p. 152-7.",{"VOID":408},"10.47972\u002Fvjcts.v26i.260","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F260",[],{"url":409,"publisher":412,"properties":431},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":413,"slug":10,"properties":414,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":419,"manageAffiliations":420,"indexDatabases":421,"url":28,"thumbnailPath":23,"statistic":422,"gsStatistic":427,"type":76,"analyzePriority":23},[],{"country":415,"issn":416,"title":417,"gsId":418},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":423,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":424,"totalCitation":49,"totalCitationByYear":425,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":426,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":428,"totalCitation":38,"totalCitationByYear":429,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":430,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":432},{"EN":230,"VI":231},{"total":30,"publishYear":434,"statisticByYear":435},2019,{},"2019-07-20","2026-08-25T01:25:13.970+00:00",[],{"id":440,"createTime":441,"updateTime":442,"relativeEntities":443,"slug":444,"properties":445,"entityType":102,"verifyStatus":22,"verifyTime":456,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":30,"primaryUrl":457,"fullTextUrl":23,"authors":458,"publicationType":151,"publisherRelationship":459,"citationCount":30,"citationInfo":481,"publishDate":483,"publishYear":284,"citationAnalyzeStatus":181,"lastCitationAnalyze":442,"indexDatabases":484,"openAccess":23,"references":23,"isForceReanalyzing":184},"d0b0b078-853b-40c7-9bd9-658413418d32","2023-05-16T02:27:29.566+00:00","2026-08-25T01:24:55.789+00:00",[],"K%E1%BA%BFt%20qu%E1%BA%A3%20ph%E1%BA%ABu%20thu%E1%BA%ADt%20tri%E1%BB%87t%20%C4%91%E1%BB%83%20t%E1%BB%A9%20ch%E1%BB%A9ng%20Fallot",{"abstract":446,"title":448,"gsPaper":450,"references":452,"doi":454},{"VI":447},"Mục đích: đánh giá kết quả phẫu thuật triệt để tứchứng Fallot tại Khoa PTT giai đoạn từ tháng 01\u002F2007tới hết tháng 09\u002F2013.Phương pháp: Phân tích đánh giá dựa trên số liệuthu được từ 65 bệnh nhân đã được phẫu thuật triệt đểcũng như từ kết quả tái khám cho 62 bệnh nhân sau mổ.Kết quả: Tuổi phẫu thuật trung bình là 12 ( 03 -40 tuổi ). Thời gian theo dõi sau mổ trung bình là 18tháng (6- 35 tháng). Phẫu thuật sửa chữa thì đầu cho63 trường hợp (96,9%); thứ phát sau khi bệnh nhânđược làm cầu nối chủ phổi là 03 trường hợp ( 4,61%).4 trường hợp ( 6,15%) mổ lại sớm; không có trườnghợp nào mổ lại muộn. 03 trường hợp ( 4,61 % ) tửvong trong khi nằm viện; không có tử vong muộn. 62trường hợp ra viện, hầu hết có cuộc sống sinh hoạtbình thường. 01 bệnh nhân còn dùng lasix và digoxinsau 3 tháng ra viện. Phương pháp phẫu thuật có mởthất phải làm tăng nguy cơ hở van ba lá nặng ( p <0,001 ) và suy thất phải (p < 0,001). Miếng vá quavòng van động mạch phổi làm tăng nguy cơ hở vanđộng mạch phổi nặng (p < 0,001 ), tăng nguy cơ suythất phải ( p < 0,001). Đánh giá liên quan của chỉ sốMcGoon và kết quả phẫu thuật.Kết luận: Kết quả phẫu thuật sửa chữa triệt để tứchứng Fallot tại Khoa PTT- BVND 115 là khả quanvới tỷ lệ tử vong tại viện 4,6 %; không có tử vongmuộn với thời gian theo dõi trung bình là 18 tháng.Hầu hết những bệnh nhân ra viện có cuộc sống bìnhthường. Phương pháp phẫu thuật cải tiến đóng TLTqua van ba lá & hạn chế mở thất P cho kết quả tốt hơnso với PP kinh điển (đóng TLT qua ngã mở thất P +vá xuyên vòng van). Chỉ số McGoon < 1 là một yếu tốtiên lượng nặng trước mổ. ",{"VI":449},"Kết quả phẫu thuật triệt để tứ chứng Fallot",{"VOID":451},"340040886502072774",{"VOID":453},"Nguyễn Hữu Ước, Đặng Hanh Đệ. Kết Quả\nBan Đầu của phẫu thuật sửa chữa toàn bộ Fallot\nở trẻ em lớn. Tạp chí Tim Mạch Học Việt Nam\nsố 28, 12- 1999 ; 46-54.\nLê Thành Khánh Vân. Chẩn Đoán và Phẫu\nThuật Sửa Chữa Toàn Bộ Tứ Chứng Fallot.\nLuận án chuyên khoa cấp II, ĐHYD tp HCM-\nNguyễn Minh Trí Viên. Kết quả điều trị của\nphẫu thuật Blalock – Taussig Trong Bệnh lý Tứ\nChứng Fallot. Luận Văn Thạc Sỹ Ngoại Lồng\nNgực, ĐHYD Tp HCM, 2002.\nChristopher J. Knott- Craig et al. A 26- Years\nExperience with Surgical Management of\nTetralogy of Fallot : Risk Analysis for Mortality\nor Late Reintervention. Ann Thorac Surg 1998 ;\n:506-11\nDietl CA et al. Life-threatening arrhythmias and\nRV dysfunction after surgical repair of tetralogy\nof fallot. Comparison between transvetricular\nand transatrial approaches. Circulation. 2004\nNov ;90( 5 Pt 2) ; II7-12\nJenifer C.Hirsch ; Edward L.Bove. Tetralogy\nof Fallot. Pediatric Cardiac Surgery. Mosby 2003\n; 383- 397 .\nKarl TR, Sano S ; Porniviliwan S ; Mee RBB.\nTetralogy of Fallot : Favorable Outcome of\nNeonatal Transatrial, Transpulmonary repair.\nAnn Thorac Surg 2002 ; 54-90\nKirklin JW ; Boyes B ; Kouchoukos NT.\nVentricular Septal Defect and Pulmonary\nStenosis or Atresia. Cardiac Surgery. Churchill\nLivingstone 2003 ; 946- 1074\nMartin A Norgaard et al. Twenty-to-thirtyseven- year follow-up after repair for Tetralogy\nof Fallot. European Journal of Cardio- thoracic\nSurgery 16 (1999) 125-130",{"VOID":455},"10.47972\u002Fvjcts.v5i.348","2023-05-16T02:27:29.565+00:00","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F348",[],{"url":457,"publisher":460,"properties":479},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":461,"slug":10,"properties":462,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":467,"manageAffiliations":468,"indexDatabases":469,"url":28,"thumbnailPath":23,"statistic":470,"gsStatistic":475,"type":76,"analyzePriority":23},[],{"country":463,"issn":464,"title":465,"gsId":466},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":471,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":472,"totalCitation":49,"totalCitationByYear":473,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":474,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":476,"totalCitation":38,"totalCitationByYear":477,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":478,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":480},{"EN":230,"VI":231},{"total":30,"publishYear":284,"statisticByYear":482},{},"2013-12-08",[],{"id":486,"createTime":487,"updateTime":488,"relativeEntities":489,"slug":490,"properties":491,"entityType":102,"verifyStatus":22,"verifyTime":504,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":69,"primaryUrl":505,"fullTextUrl":23,"authors":506,"publicationType":151,"publisherRelationship":507,"citationCount":30,"citationInfo":529,"publishDate":235,"publishYear":233,"citationAnalyzeStatus":181,"lastCitationAnalyze":531,"indexDatabases":532,"openAccess":23,"references":23,"isForceReanalyzing":184},"4c40c2be-a9bf-4c4a-8a45-a3aac5077385","2023-05-16T02:30:36.270+00:00","2026-08-25T01:04:22.225+00:00",[],"Study%20on%20platelet%20count%20and%20aging%20in%20patients%20suffer%20from%20cardiac%20diseases%20and%20others.",{"abstract":492,"title":495,"gsPaper":498,"references":500,"doi":502},{"EN":493,"VI":494},"To explore the relationship between age, sex and number of peripheral blood platelets in patients being treated at the Heart Center. 7847 patients examined and treated at the Heart Centre. About 45% sex with men and 55% women; Of age from 0 to 4, 5-9, 10-14, 15-17, 18-34, 35-49, 50-64, 65-74, and over 75 years old and with platelet counts in males respectively there are 306.1 ± 106.47 G\u002Fl; 267.47 ± 86.79 G\u002Fl; 255.32 ± 76.10 G\u002Fl; 222.22 ± 75.09 G\u002Fl; 208.23 ± 57.02 G\u002Fl; 210.73 ± 61.09 G\u002Fl; 211.55 ± 63.49 G\u002Fl; 206.50 ± 66.42 G\u002Fl, 205.96 ± 63.6 G\u002Fl; and in females respectively 305.53 ± 108.65 G\u002Fl; 257.31 ± 78.85 G\u002Fl; 237.7 ± 72.71 G\u002Fl; 236.93 ± 63.21 G\u002Fl; 224.97 ± 57.83 G\u002Fl; 233.88 ± 62.81 G\u002Fl; 221.93 ± 58.84 G\u002Fl; 222.35 ± 59.12 G\u002Fl; 215.59 ± 108.65 G\u002Fl. Normal platelet counts proportion 86.4%, decreased 9.7% and increase 3.9%. The average platelet count tends to rise in young age groups and decreased in the older age groups. In 15-74 years old and over 75 years the averages platelet in the women are more than in the men, and tend to decrease after menopause","Tìm hiểu sự liên quan giữa tuổi, giới và số lượng tiểu cầu máu ngoại vi ở 7847 bệnh nhân được điều trị tại trung tâm tim mạch. Về giới tính có 45 % nam và 55 % nữ; Về độ tuổi từ 0 đến 4, 5-9, 10-14, 15-17, 18-34, 35-49, 50-64, 65-74, và từ 75 tuổi trở lên với số lượng tiểu cầu ở nam lần lượt là 306,1 ± 106,47 G\u002Fl; 267,47 ± 86,79 G\u002Fl; 255,32 ± 76,10 G\u002Fl; 222,22 ± 75,09 G\u002Fl; 208,23 ± 57,02 G\u002Fl; 210,73 ± 61,09 G\u002Fl; 211,55 ± 63,49 G\u002Fl; 206,50 ± 66,42 G\u002Fl, 205,96 ± 63,6 G\u002Fl; ở nữ lần lượt là 305,53 ± 108,65 G\u002Fl; 257,31± 78,85 G\u002Fl; 237,7 ± 72,71 G\u002Fl; 236,93 ± 63,21 G\u002Fl; 224,97 ± 57,83 G\u002Fl; 233,88 ± 62,81 G\u002Fl; 221,93 ± 58,84 G\u002Fl; 222,35 ± 59,12 G\u002Fl; 215,59 ± 108,65 G\u002Fl. Số lượng tiểu cầu bình thường chiếm tỷ lệ 86,4%, giảm chiếm 9,7% và tăng chiếm 3,9%. Số lượng tiểu cầu trung bình có xu hướng tăng hơn ở nhóm tuổi nhỏ và giảm dần ở các nhóm tuổi lớn hơn. Số lượng tiểu cầu trung bình ở nữ cao hơn nam ở độ tuổi từ 15-74 tuổi và trên 75 tuổi, và có xu hướng giảm dần sau thời kỳ mãn kinh.",{"EN":496,"VI":497},"Study on platelet count and aging in patients suffer from cardiac diseases and others.","Nghiên cứu sự thay đổi số lượng tiểu cầu ở bệnh nhân tim mạch điều trị tại trung tâm tim mạch - bệnh viện E từ tháng 1 năm 2013 đến tháng 5 năm 2016",{"VOID":499},"14747305145246203138",{"VOID":501},"Nguyễn Công Khanh (2008) “Huyết học lâm sàng nhi khoa” NXB Y học: 24-45.\nNguyễn Quang Tùng, Trần Mai Hồng (2012) “nghiên cứu sự thay đổi một số chỉ số huyết học ở bệnh nhân tim bẩm sinh” Tạp chí Y học Việt Nam, tập 396: 226-230.\nTrường Đại học Y Hà Nội, Bộ môn Nhi (2009)“Bài giảng nhi khoa” tập 2 NXB Y học.\nTrường Đại học Y Hà Nội, Bộ môn Huyết học- Truyền máu “Bài giảng Huyết học Truyền máu” NXH Y học 2004.\nBeguin Y. Erythropoietin and platelet production. Haematologica1999; 84(6): 541–7 • Biino G, Gasparini P, D’Adamo P, Ciullo M, Nutile T, Toniolo D, et al. Influence of age, sex and ethnicity on platelet count in five Italian geographic isolates: mild thrombocytopenia may be physiological. Br J Haematol 2012; 157(3):384–7\nBiino G, Santimone I, Minelli C, Sorice R, Frongia B, Traglia M, et al. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects’ data. PLoS One 2013;8(1):e54289.\nBuckley MF, James JW, Brown DE, Whyte GS, Dean MG, Chesterman CN, et al. A novel approach to the assessment of variations in the human platelet count. Thromb Haemost2000;83(3):480–4\nKadikoylu G, Yavasoglu I, Bolaman Z, Senturk T. Platelet parameters in women with iron deficiency anemia. J Natl Med Assoc2006;98(3): 398–402\nNagata Y, Yoshikawa J, Hashimoto A, Yamamoto M, Payne AH, Todokoro K. Proplatelet formation of megakaryocytes is triggered by autocrine-synthesized estradiol. Genes Dev2003;17(23):2864–9\nSantimone I, Di Castelnuovo A, De Curtis A, Spinelli M, Cugino D, Gianfagna F, et al. White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica2011;96(8):1180–8\nSegal JB, Moliterno AR. Platelet counts differ by sex, ethnicity, and age in the United States. Ann Epidemiol 2006;16(2):123–30\nSloan AW. The normal platelet count in men. J Clin Path1951;4(1):37–46 • Stasi R, Amadori S, Osborn J, Newland AC, Provan D. Long-term outcome of otherwise healthy individuals with incidentally discovered borderline thrombocytopenia. PLoS Med 2006;3(3):e24.\nStevens RF, Alexander MK. A sex difference in the platelet count.Br J Haematol 1977;37(2):295–300",{"VOID":503},"10.47972\u002Fvjcts.v14i.171","2023-05-16T02:30:36.269+00:00","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F171",[],{"url":505,"publisher":508,"properties":527},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":509,"slug":10,"properties":510,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":515,"manageAffiliations":516,"indexDatabases":517,"url":28,"thumbnailPath":23,"statistic":518,"gsStatistic":523,"type":76,"analyzePriority":23},[],{"country":511,"issn":512,"title":513,"gsId":514},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":519,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":520,"totalCitation":49,"totalCitationByYear":521,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":522,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":524,"totalCitation":38,"totalCitationByYear":525,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":526,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":528},{"EN":230,"VI":231},{"total":30,"publishYear":233,"statisticByYear":530},{},"2026-08-25T01:04:22.224+00:00",[],{"id":534,"createTime":535,"updateTime":536,"relativeEntities":537,"slug":538,"properties":539,"entityType":102,"verifyStatus":22,"verifyTime":535,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":550,"primaryUrl":551,"fullTextUrl":23,"authors":552,"publicationType":151,"publisherRelationship":553,"citationCount":30,"citationInfo":575,"publishDate":577,"publishYear":233,"citationAnalyzeStatus":181,"lastCitationAnalyze":578,"indexDatabases":579,"openAccess":23,"references":23,"isForceReanalyzing":184},"c0654018-d0d3-405e-9a6c-e14ea034083c","2023-05-16T02:29:50.931+00:00","2026-08-25T01:03:42.236+00:00",[],"A%20case%20study%20of%20recurrent%20hemagiopericytoma%20of%20the%20left%20lung",{"abstract":540,"title":542,"gsPaper":544,"references":546,"doi":548},{"EN":541},"Hemangiopericytoma is a rare disease. We report the first case presented with such disease at our hospital. The patient was first diagnosed with is vascular tumour 10 years ago and was discharged without chemotherapy. The patient was recently hospitalised due to tumour recurrence. The patient was Mrs. Tran Thi Kim H, was born in 1970, married, had 4 children, and was a farmer. The patient lived at An thoi Đong, Can Gio district, and was admitted on 26\u002F9\u002F2019 due to a recurrent left lung tumour. The patient suffered from headache and vertigo in the past 2 years and she underwent surgical removal of a lung tumour 10 years ago at Binh Dan Hospital. Physical examination was normal. Laboratory results were within normal range, except a mild anaemia. We had planned to use thoracoscopy but after general anaesthesia, the left lung could not be deflated and therefore the surgery was postponed. A week after, we attempted to use thoracotomy. We observed a tumour that adhered to the thoracic wall and to the left lung. We dissected the adhesion and removed the tumour, haemostasis was achieved by suturing with a Vicryl 3.0 stitch. The surgical incision was closed and a chest drainage was placed. Post-operative follow-up was uneventful and the patient stayed in the hospital for 15 days. Pathological studies: Biopsy with MSCT guidance revealed a diagnosis of undifferentiated non-small cell lung cancer; surgical biopsy showed that this was a lymphocyte with big cell tumour. Finally, the diagnosis of lung hemangiopericytoma was confirmed by immunohistochemistry. Whether chemotherapy should be indicated for this patient is being considered. ",{"EN":543,"VI":543},"A case study of recurrent hemagiopericytoma of the left lung",{"VOID":545},"15769996240034754122",{"VOID":547},"Barjas R,Piccioni DE Malignant hemangiopericytoma: Treatment patterns and survival. J Clinical Oncology 35, no. 15_suppl. DOI: 10.1200\u002FJCO.2017.35.15_suppl.e13520.\n- Briselli M, Mark EJ, Dikerson GR: Solitaty fibrous tumor of the pleura, eight new cases and review of 360 cases in the literature. Cancer 1981; 47:2678-2689.\n- Chnaris A, Barberaki N, Efstarhieu A et al: Primary mediastinal hemangiopericytoma. World J Surg Oncol 2006, 4-23.\n- Damodaran O, Robbins P, Knuckey et al: Primary intracranien hemangiopericytoma, comparison of survival outcomes and metastatic potential in WHO grade II and III variants. J Clin Neurosci 21:1310-1314, 2014 .\n- Fuijita A, Minase T, Takabatake H et al: A case of primary malignant hemangiopericytoma of the lung with marked response in combination chemotherapy with cisplatin, ifosfamide and gentamycine Japanese J Cancer and Chemotherapy, 2001; 28:373-376.\n- Fletcher CDM: Diagnosis histopatology of tumor. 2nd ed London, UK Churchill Livingstone, 2000:77-80.\n-Enzinger FM, Smith BH: Hemangiomapericytoma. An analysis of 106 cases. Hum pathol 1976, 7:61-82 .\n- Gengler C, Guillon I.: Solitary fibrous tumor and hemangiopericytoma evolution of a concept. Histopathology 2006; 48:63-74.\n- Guthrie BL, Ebersold MJ, Scheithauer BW et al: Meningeal hemangiopericytoma histopathological feature, treatment, and long- term follow up of 44 cases. Neurosurgery 25:514-522, 1989.\n- Ghose A, Guha G, Kundu R et al: CNS hemangiopericytoma: a systemic review of 523 patients. Am J clin 40:223-227, 2017.\n- Hallen M, Parada LA, Goeunova L et al: Cytogenic abnormalities in a hemagiopericytoma of the spleen. Cancer Genet Cytogenet 2002,136: 62-65 .\n- Hugle WP: Malignant hemangiopericytoma. A clinical overview and case study. Clin J Oncol 2003:7:57-62.\n- Kaminska I, S-Wojcik E, Kudsinski P et al: Primary lung hemangiopericytoma: a rare neoplasm with a long course of recurrence over many years. Pneumonol Alergol Pol 2001,69: 290-294.\n- Lee SJ, Kim ST, Park SH et al: Successful use of pazopanib for treatment of refractory metastatic hemangiopericytoma. Division of Hematology-Oncology, dpt of Medecine Samsung, Seoul 135-710, Korea.\n- Penel N, Amela EY, Decanter G, Robin YM, Marec- Berard P. Solitary Fibrous Tumors and So-Called Hemangiopericytoma. Volume 2012, Article ID 690251, doi:10.1155\u002F2012\u002F69025.\n- Radulescu D, Pripon S, Ciuleanu TE, et al: Malignant primary tumor with hemangiopericytoma-like feature: conventional hemangiopericytoma versus solitary fibrous tumor. Clinical lung cancer, vol 8, No 8, 504- 508, 2007.\n- Stout AP and Murray MR: Hemagiopericytoma a vascular tumor featuring Zimmerman’s pericytes. Ann Surg 1942, 116:26-32.\n- Sung KS, Moon JH, Kim EH et al: Solitary fibrous tumor\u002Fhemangiopericytoma. Treatment results based on the 2016 WHO classification. J Neurosurg, March 9, 2018.\n- Van de Rijn M, Lombard CM, Rouse RV: Expression of CD34 by solidary fibrous tumors of pleura, mediastinum and lung. Am J Surg Pathol 1994,18:815-820.\n- Tulay Akman, Ahmet Alacacioglu, Devrim Dolek, Tugba Unek, Duygu Gurel, Ahmet Ugur Yilmaz, and Ahmet Onen . Malign Recurrence of Primary Chest Wall Hemangiopericytoma in the Lung after Four Years : A Case Report and Review of the Literature. Hindawi, Volume 2014, Article ID 470268, http:\u002F\u002Fdx.doi.org\u002F10.1155\u002F2014\u002F470268.",{"VOID":549},"10.47972\u002Fvjcts.v28i.394",26,"https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F394",[],{"url":551,"publisher":554,"properties":573},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":555,"slug":10,"properties":556,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":561,"manageAffiliations":562,"indexDatabases":563,"url":28,"thumbnailPath":23,"statistic":564,"gsStatistic":569,"type":76,"analyzePriority":23},[],{"country":557,"issn":558,"title":559,"gsId":560},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":565,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":566,"totalCitation":49,"totalCitationByYear":567,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":568,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":570,"totalCitation":38,"totalCitationByYear":571,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":572,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":574},{"EN":230,"VI":231},{"total":30,"publishYear":233,"statisticByYear":576},{},"2020-03-23","2026-08-25T01:03:42.235+00:00",[],{"id":581,"createTime":582,"updateTime":583,"relativeEntities":584,"slug":585,"properties":586,"entityType":102,"verifyStatus":22,"verifyTime":582,"verifyNote":205,"languages":23,"translateLanguages":23,"viewCount":52,"primaryUrl":599,"fullTextUrl":23,"authors":600,"publicationType":151,"publisherRelationship":601,"citationCount":30,"citationInfo":623,"publishDate":235,"publishYear":233,"citationAnalyzeStatus":181,"lastCitationAnalyze":625,"indexDatabases":626,"openAccess":23,"references":23,"isForceReanalyzing":184},"e581efca-9e26-4f3f-ba49-e1a806768f0b","2023-05-16T02:28:45.968+00:00","2026-08-25T01:02:05.146+00:00",[],"K%E1%BA%BFt%20qu%E1%BA%A3%20b%C6%B0%E1%BB%9Bc%20%C4%91%E1%BA%A7u%20%C3%A1p%20d%E1%BB%A5ng%20k%E1%BB%B9%20thu%E1%BA%ADt%20%C4%91o%20b%C3%A3o%20h%C3%B2a%20oxy%20m%C3%A1u%20t%C4%A9nh%20m%E1%BA%A1ch%20tr%E1%BB%99n%20%C4%91%E1%BB%83%20theo%20d%C3%B5i%20huy%E1%BA%BFt%20%C4%91%E1%BB%99ng%20b%E1%BB%87nh%20nh%C3%A2n%20ph%E1%BA%ABu%20thu%E1%BA%ADt%20tim%20c%C3%B3%20nguy%20c%C6%A1%20cao",{"abstract":587,"title":590,"gsPaper":593,"references":595,"doi":597},{"EN":588,"VI":589},"With more and more hospitals establishing and\u002For expanding their open-heart surgery programs, it is important for clinicians to have a clear understanding of the methods used for patient monitoring. One of the most versatile and probably most misunderstood, is mixed venous oxygen saturation (S O2) and how it relates to cardiac function, oxygen delivery (DO2) and oxygen consumption (VO2).We randomized 60 patients undergoing elective cardiac surgery to a protocol involving the administration of intravenous fluid and inotropic therapy to attain a target S O2 of at least 70% in first 8h after surgery. Dobutamine was administered in dose of up to 15μg\u002Fkg\u002Fmin where the target S O2 was not achieved with intravenous fluid alone.Control group patients were administered intravenous fluid and dobutamine to meet goals for pulmonary artery occlusion pressure, cardiac index, arterial pressure, and hematocrit. S O2 was similar in two groups at baseline (67±6%), but there were greater improvements in S O2 in the S O2 group(control group 69±5% vs. S O2 group 71±4%; p<0,001). S O2 guided therapy was associated with a reduction in both ICU stay (29,23±7,82 vs. 40,27 ± 9,04 hours; p<0,001) and the number of patients developing complicationsHemodynamic therapy to attain a target value for S O2 is more appropriate in this context as confounding causes of decreased venous saturation are minimized. This treatment is possible after cardiac surgery where postoperative intensive care admission is a standard of care ","Trước nhu cầu triển khai và phát triển chương trình phẫu thuật tim ngày càng tăng tại các bệnh viện, điều quan trọng là các nhà hồi sức cần hiểu rõ các phương pháp theo dõi và hồi sức bệnh nhân sau mổ tim. Một trong những phương pháp hữu ích nhất và có lẽ chưa được nghiên cứu nhiều là kỹ thuật đođộ bão hòa oxy máu tĩnh mạch trộn (S O2), cũng như mối tương quan giữa chỉ số này với chức năng tim, khả năng vận chuyển oxy cho mô (DO2) và tiêuthụ oxy của cơ thể (VO2). Chúng tôi tiến hành nghiên cứu ngẫu nhiên trên 60 bệnh nhân được phẫu thuật tim với phác đồ hồi sức huyết động bao gồm bù dịch thích đáng và sử dụng inotrop nhằm mục đích đạt giá trị đích S O2≥70% trong 8h đầu sau mổ. Dobutamine sẽ được sử dụng cho đến liều 15μg\u002Fkg\u002Fphút nếu như S O2 chưa đạt đích với liệu pháp bù dịch đơn thuần.Nhóm chứng được hồi sức tương tự nhưng theo mục đích đạt giá trị đích của áp lực động mạch phổi bít, chỉ số tim, huyết áp động mạch, và hematocrit. Giá trị S O2 là tương tự giữa 2 nhóm ở thời điểm ban đầu (67±6%), nhưng có sự cải thiện tốt hơn giá trị này ở nhóm S O2 (69±5% ở nhóm chứng so với 71±4% ở nhóm S O2 ; p<0,001). Hồi sức theo hướng dẫn S O2 giúp cải thiện thời gian điều trị ở phòng hồi sức (29,23±7,82 vs. 40,27 ± 9,04 giờ; p<0,001) và cải thiện các biến chứng sau mổ.Hồi sức huyết động nhằm đạt giá trị đích S O2 rất thích hợp trong bối cảnh bệnh nhân có nhiều nguyên nhân phức tạp gây giảm bão hòa oxy máu tĩnh mạch. Khuynh hướng theo dõi giá trị S O2 như là một phương thức chuẩn để hồi sức các bệnh nhân sau phẫu thuật tim ngày nay.",{"EN":591,"VI":592},"Kết quả bước đầu áp dụng kỹ thuật đo bão hòa oxy máu tĩnh mạch trộn để theo dõi huyết động bệnh nhân phẫu thuật tim có nguy cơ cao","KẾT QUẢ BƯỚC ĐẦU ÁP DỤNG KỸ THUẬT ĐO BÃO HÒA OXY MÁU TĨNH MẠCH TRỘN ĐỂ THEO DÕI HUYẾT ĐỘNG BỆNH NHÂN PHẪU THUẬT TIM CÓ NGUY CƠ CAO",{"VOID":594},"7255563528721290114",{"VOID":596},"Eagle K. A., Brundage B. H., Chaitman, BR et al: ”Guidelines for perioperative cardiovascular evaluation for cardiac surgery”. Circulation 2009; 93: 1278 – 1317 and JACC 2009, 27: 910 – 948\nEdward Lifesciences “Understanding continuous mixed venous oxygen saturation (S O2) monitoring with the Swan-Ganz oximetry TD System” 3rd Edition 2011; 1161 – 11\u002F00 – CC.\nESCAPE Investigators and ESCAPE Study Coordinators: \"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness” 2010 the ESCAPE trial, Journal of American Medical Association, pp. 1625 – 1633.\nRichard C., Monet X., Anguel N., Teboul J. L., : “Évaluation d’intérêt d’un outil de monitoring : le cathéter artériel pulmonaire”. Insuffisance Circulatoire Aigue, © 2009 Elservier Masson SAS. Shoemaker W. C., Appel P. L., Kram H. B., Waxman K. and Lee T. S. : “Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients”. Official publication of the American College of Chest physicians 2008; 1176 – 1186.",{"VOID":598},"10.47972\u002Fvjcts.v1i.130","https:\u002F\u002Fvjcts.vn\u002Findex.php\u002Fvjcts\u002Farticle\u002Fview\u002F130",[],{"url":599,"publisher":602,"properties":621},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":603,"slug":10,"properties":604,"entityType":21,"verifyStatus":22,"verifyTime":23,"verifyNote":23,"languages":23,"translateLanguages":23,"viewCount":24,"subjectFields":609,"manageAffiliations":610,"indexDatabases":611,"url":28,"thumbnailPath":23,"statistic":612,"gsStatistic":617,"type":76,"analyzePriority":23},[],{"country":605,"issn":606,"title":607,"gsId":608},{"VOID":13},{"VOID":15},{"EN":17,"VI":18},{"VOID":20},[],[],[],{"impactFactor":30,"impactFactorByYear":613,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":36,"totalPublicationByYear":614,"totalCitation":49,"totalCitationByYear":615,"totalCitationPerPublication":56,"totalCitationPerPublicationByYear":616,"hindexLast5Year":51,"hindex":51},{"2021":32,"2022":33,"2023":34,"2024":35},{"2013":38,"2014":39,"2016":40,"2018":41,"2019":42,"2020":43,"2021":44,"2022":45,"2023":46,"2024":47,"2025":48},{"2013":51,"2014":52,"2016":52,"2018":52,"2019":39,"2020":53,"2021":38,"2022":54,"2023":55},{"2013":58,"2014":59,"2016":60,"2018":34,"2019":61,"2020":62,"2021":63,"2022":64,"2023":65},{"impactFactor":23,"impactFactorByYear":23,"i10Index":30,"i10IndexLast5Year":30,"totalPublication":67,"totalPublicationByYear":618,"totalCitation":38,"totalCitationByYear":619,"totalCitationPerPublication":73,"totalCitationPerPublicationByYear":620,"hindexLast5Year":69,"hindex":69},{"0":52,"2014":69,"2020":70,"2021":52,"2022":69},{"2020":72,"2021":52,"2022":52,"2023":51,"2024":51,"2025":54,"2026":69},{"2020":62,"2021":52,"2022":75},{"title":622},{"EN":230,"VI":231},{"total":30,"publishYear":233,"statisticByYear":624},{},"2026-08-25T01:02:05.145+00:00",[]]